FMR LLC 13D and 13G filings for Kinnate Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | KINNATE BIOPHARMA INC KNTE | FMR LLC | 2,092,523 4.788% | -357,612 (-14.60%) | Filing |